Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Peter M. Abuja is active.

Publication


Featured researches published by Peter M. Abuja.


Clinica Chimica Acta | 2001

Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins

Peter M. Abuja; Riccardo Albertini

After a brief discussion of lipid peroxidation mechanism and the action of antioxidants and their potential to exhibit prooxidant effects, we give an overview on the clinical relevance of oxidative stress parameters. Many diseases are associated with oxidative stress e.g. by radical damage, among them atherosclerosis, diabetes mellitus, chronic renal failure, rheumatoid arthritis, and neurodegenerative diseases, and in many cases the investigation of parameters of oxidative stress has brought substantial insights into their pathogenesis. We then briefly review methods for the continuous monitoring of lipid peroxidation processes in vitro, which has helped in elucidating their mechanism and in some more detail cover such methods which have been proposed more recently to assess oxidative status and antioxidant activity in biological samples.


FEBS Letters | 1999

ASCORBATE PREVENTS PROOXIDANT EFFECTS OF URATE IN OXIDATION OF HUMAN LOW DENSITY LIPOPROTEIN

Peter M. Abuja

Uric acid and ascorbic acid are important low molecular weight antioxidants in plasma. Their interactions and combined effect on Cu2+‐catalysed oxidation of human low density lipoprotein were studied in vitro. It was found that uric acid alone becomes strongly prooxidant whenever it is added to low density lipoprotein shortly after the start of oxidation (conditional prooxidant). Ascorbic acid, which is present in human plasma at much lower concentrations (20–60 μM) than urate (300–400 μM), is in itself not a conditional prooxidant. Moreover, ascorbate prevents prooxidant effects of urate, when added to oxidising low density lipoprotein simultaneously with urate, even at a 60‐fold molar excess of urate over ascorbate. Ascorbate appears to have the same anti‐prooxidant effect with other aqueous reductants, which, besides their antioxidant properties, were reported to be conditionally prooxidant. Such interactions between ascorbate and urate may be important in preventing oxidative modification of lipoproteins in the circulation and in other biological fluids.


European Biophysics Journal | 1988

Structural and functional domains of cellobiohydrolase I from trichoderma reesei

Peter M. Abuja; M. Schmuck; Ingrid Pilz; P. Tomme; M. Claeyssens; Hermann Esterbauer

Limited proteolysis (papain) of the cellobiohydrolase I (CBH I, 65 kDa) from Trichoderma reesei led to the seperation of two functional domains: a core protein (55 kDa) containing the active site, and a C-terminal glycopeptide (10 kDa) implicated in binding to the insoluble matrix (cellulose). The quaternary structures of the intact CBH I and its core in solution are now compared by small angle X-ray scattering (SAXS) measurements. The molecular parameters derived for the core (Rg=2.09 nm, Dmax=6.5 nm) and for the intact enzyme (Rg=4.27 nm, Dmax=18 nm) indicate very different shapes. The resulting models show a “tadpole”-like structure for the intact enzyme where the isotropic part coincides with the core protein and the flexible tail part should be identified with the C-terminal glycopeptide. Thus in this enzyme, functional differentiation is reflected in structural peculiarities.


Free Radical Biology and Medicine | 1998

Copper Can Promote Oxidation of LDL by Markedly Different Mechanisms

Ouliana Ziouzenkova; Alex Sevanian; Peter M. Abuja; Pilar Ramos; Hermann Esterbauer

Oxidation of LDL (0.1 microM) in PBS with copper concentrations ranging from 0.03 to 10 microM, equal to 0.3-100 Cu2+/LDL, was investigated by monitoring the formation of conjugated dienes at 234 nm. With all 8 LDL samples examined, the kinetics changed strongly at submicromolar Cu2+ concentrations. Based on time-course of the formation of conjugated dienes, cholesteryl linoleate hydroxides and hydroperoxides as well as the antioxidant consumption, two oxidation types were distinguished. Type A oxidations, observed at relatively high Cu2+ concentrations of 10-100 Cu2+/ LDL, represented the conventional kinetics of LDL oxidation with an inhibition period (= lag-time) followed by a propagation phase. In contrast, type C oxidations proceeded after a negligibly short lag time followed by a distinct propagation phase. The rate of this propagation increased rapidly to 0.5 mol diene/mol LDL and then slowed down in the presence of alpha-,gamma-tocopherols and carotenoids, which were consumed faster than tocopherols. The increase in diene absorption was due to the formation of both hydroxides and hydroperoxides suggesting a high initial decomposition of hydroperoxides. At submicromolar concentrations of about 0.1 to 0.5 microM, type C and type A oxidation can be combined resulting in 4 consecutive oxidation phases, i.e. 1st inhibition and 1st propagation (belonging to type C), followed by 2nd inhibition and 2nd propagation (belonging to type A). Increasing copper concentrations lowered the 1st propagation and shortened the 2nd inhibition periods until they melted into one apparent kinetic phase. Decreasing [Cu2+] increased the 1st propagation and 2nd inhibition but lowered the 2nd propagation phase until it completely disappeared. A threshold copper concentration, denoted as Cu(lim), can be calculated as a kinetic constant based on the Cu2+-dependence for the rate of 2nd propagation. Below Cu(lim), LDL oxidation proceeds only via type C kinetics. The Cu2+-dependence of the oxidation kinetics suggests that LDL contains two different Cu2+ biding sites. Cu2+ at the low-affinity binding sites, with half-saturation at 5-50 Cu2+/LDL, initiates and accelerates the 2nd propagation by decomposing lipid hydroperoxides. Cu2+ bound to the high-affinity binding sites, with half-saturation at 0.3-2.0 Cu2+/LDL, is responsible for the 1st propagation. Arguments in favor and against this propagation being due to tocopherol mediated peroxidation (TMP) are discussed. If the lag-time concept is extended to the conjugated diene curves seen for combined oxidation profiles, then a true inhibition phase does not apply to this time interval, but instead represents the time elapsed before the onset of the 2nd propagation phase.


FEBS Letters | 2001

Prooxidant activity of melatonin promotes fas-induced cell death in human leukemic Jurkat cells.

Albert Wölfler; Hans-Christian Caluba; Peter M. Abuja; Gottfried Dohr; Konrad Schauenstein; Peter M. Liebmann

The antioxidant activity of melatonin (MEL) has been considered to constitute part of its physiological as well as pharmacological effects. However, as described herein we found a profound prooxidant activity of micro‐ to millimolar concentrations of MEL in the human leukemic Jurkat cell line. This prooxidant effect was increased in glutathione‐depleted cells and counteracted by antioxidants. As a consequence MEL promoted fas‐induced cell death. These data therefore indicate that MEL may be a modulator of the cellular redox status, but does not necessarily act as an intracellular antioxidant.


FEBS Letters | 1997

Antioxidant role of melatonin in lipid peroxidation of human LDL

Peter M. Abuja; Peter M. Liebmann; Marianne Hayn; Konrad Schauenstein; Hermann Esterbauer

It is concluded that melatonin is not incorporated into LDL in sufficient concentrations to prevent lipid peroxidation effectively. When melatonin is present in the incubation medium during oxidation, a partitioning equilibrium between aqueous and lipid phase is established. Only under these conditions can melatonin act as a chain breaking antioxidant. The concentrations required, however, are far beyond those found in human plasma. Therefore, the data in this study do not support a direct physiological relevance of melatonin as an antioxidant in lipid peroxidation processes.


FEBS Letters | 1999

N-acetylserotonin is a better extra- and intracellular antioxidant than melatonin

Albert Wölfler; Peter M. Abuja; Konrad Schauenstein; Peter M. Liebmann

Both melatonin and its precursor N‐acetylserotonin have been reported to exert antioxidant properties both in vitro and in vivo. Since little is known about their antioxidant activity in lymphocytes, we investigated their effects on spontaneous and on oxidant‐induced reactive oxygen species formation in human peripheral blood lymphocytes in comparison to the antioxidant trolox, a water‐soluble analogue of α‐tocopherol. Both melatonin and N‐acetylserotonin exhibited antioxidant properties against t‐butylated hydroperoxide‐ and diamide‐induced reactive oxygen species formation in peripheral blood lymphocytes. N‐acetylserotonin turned out to be about three times more effective than melatonin. In resting cells, the intracellular reactive oxygen species concentration was only decreased by N‐acetylserotonin and trolox, melatonin had no effect. In t‐butylated hydroperoxide‐mediated cell death, N‐acetylserotonin was as effective as trolox in protecting peripheral blood lymphocytes from cell death and required 10‐fold lower concentrations than melatonin. Furthermore, in an aqueous cell‐free solution, the capacity of N‐acetylserotonin to scavenge peroxyl radicals was much higher than that of melatonin. These results clearly indicate N‐acetylserotonin to be a much better antioxidant than melatonin.


Atherosclerosis | 2000

Relationship between classic risk factors, plasma antioxidants and indicators of oxidant stress in angina pectoris (AP) in Tehran

S. Meraji; Peter M. Abuja; Matthew H. Hayn; Gert M. Kostner; Richard Morris; S. Oraii; Franz Tatzber; W. Wonisch; Rudolf Zechner; K.F. Gey

Cardiovascular disease (CVD) in general seems to be the leading cause of death in the Eastern Mediterranean Region (EMR) including Iran. This may be due to classic risk factors such as high triglyceride (TG), high total cholesterol (TC), and low levels of high density lipoprotein cholesterol (HDL-C). The impact of antioxidants as potentially protective risk factors against early coronary heart disease (CHD) is unknown in Iran. Therefore, relationships between angina and plasma antioxidants and indicators of lipid peroxidation were investigated in a case-control study. In this study, 82 cases of previously undiagnosed angina pectoris (AP), identified by a modified WHO Rose chest pain questionnaire and verified by electrocardiography during treadmill exercise testing, were compared with 146 controls selected from the same population of over 4000 male civil servants aged 40-60 years. Subjects with AP declared significantly less physical activity and had higher serum TG [means (S.E.M.) 2.32 (0.18) versus 1.61 (0.07) mmol/l] but lower HDL-C [1.01 (0.04) versus 1.18 (0.03) mmol/l] than age-matched controls. Levels of total serum cholesterol, low-density lipoprotein cholesterol (LDL-C) and lipoprotein(a) [Lp(a)] were not significantly different between the two groups, while the ratio of LDL-C/HDL-C was significantly higher [4.51 (0.23) versus 3.54 (0. 11)] for subjects with AP than for the controls. There was no significant difference in plasma levels of alpha-tocopherol, vitamin C, alpha- and beta-carotene. However, retinol [1.90 (0.06) versus 2. 09 (0.05)] and beta-cryptoxanthin [0.398 (0.04) versus 0.467 (0.03)] were significantly lower in AP. Furthermore, angina cases exhibited a higher index of lipid peroxidation than controls (e.g. malondialdehyde, MDA; 0.376 (0.010) versus 0.337 (0.009) micromol/l). On multiple logistic regression analysis, retinol with odds ratio (OR) of 0.644 [95% confidence interval (CI; 0.425-0.978)], beta-cryptoxanthin, with an OR of 0.675 (CI; 0.487-0.940), oxidation indices, MDA with OR of 1.612 (95% CI; 1.119-2.322) and LDL-C/HDL-C ratio with OR of 2.006 (95% CI; 1.416-2.849) showed the most significant independent associations with AP in this group of Iranians. In conclusion, the state of lipid peroxidation as well as the status of special antioxidants may be co-determinants of AP in Iran, in parallel with the influence of classical risk factors for cardiovascular disease.


Free Radical Research | 1998

Monitoring of low density lipoprotein oxidation by low-level chemiluminescence.

Riccardo Albertini; Peter M. Abuja

A method for monitoring low-density lipoprotein (LDL) oxidation by low-level chemiluminescence (LL-CL) is described in this study. The kinetic indices obtained with this procedure, in particular lag-time and K value (related to prooxidant activity of Cu2+ bound to LDL) are compared with those of the established UV-absorbing conjugated diene assay. The correlation of lag-time values obtained by LL-CL and conjugated diene assay was very high both in the case of Cu2+- and peroxyl-radical-mediated oxidation (r = 0.99). By using the transient free radical scavenging activity of butylated hydroxytoluene, a calibration of LL-CL for lipid peroxyl radical and termination rate was obtained. The spectral analysis of LL-CL from oxidizing LDL shows a maximum peak between 420 and 500 nm, corresponding to the emission of triplet carbonyl compounds. LL-CL allows continuous and direct monitoring of LDL oxidation as extraction and derivatization of lipid peroxidation products are not required. Moreover, some limitations of UV spectroscopy such as by absorbing compounds need not be considered. Therefore, the present procedure represents a simple and convenient tool for continuous monitoring of LDL oxidation which may be applied to mechanistic and clinical studies.


FEBS Letters | 2001

Hypochlorite induces the formation of LDL(-), a potentially atherogenic low density lipoprotein subspecies.

Judith S. Fabjan; Peter M. Abuja; R. Joerg Schaur; Alex Sevanian

Oxidation of low density lipoprotein (LDL) induced by hypochlorous acid (HOCl) leading to LDL−, a minimally oxidized subspecies of LDL, was investigated. LDL− is characterized by its greater electronegativity and oxidative status, and is found in plasma in vivo. Its concentration was found to be elevated under conditions that predispose humans to atherosclerosis. We found that HOCl also converts LDL rapidly to an even more oxidized state, identified as LDL2−, which is more electronegative than LDL−. After milder oxidation for short durations, formation of LDL− takes place while less LDL2− is formed. Under these conditions, addition of methionine not only suppressed further oxidation of LDL but also favored the formation of LDL− over LDL2−, possibly by removing chloramines at lysyl residues of LDL. The presence of lipoprotein‐deficient plasma did not prevent HOCl‐mediated conversion of LDL to more electronegative species. It is concluded that the HOCl‐mediated conversion of LDL into more electronegative species might be physiologically relevant.

Collaboration


Dive into the Peter M. Abuja's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kurt Zatloukal

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar

Peter Laggner

Austrian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Ruth Prassl

Medical University of Graz

View shared research outputs
Researchain Logo
Decentralizing Knowledge